Close Menu

Intermountain Healthcare

Health systems' molecular testing labs haven't had to cut back on genomic profiling for cancer patients yet but may need to accommodate COVID-19 testing if needed.

The mCODE team recently released standards for inputting genomic and other data into patient records to boost patient record transferability and trial participation.

Before broad implementation, the healthcare system will gauge the feasibility of the screening program, patient impact, and cost-benefit in a pilot phase.